New cream shows promise for rare, severe skin condition
Disease control
Completed
This study tested a cream called SXR1096 in 9 people with Netherton syndrome, a rare genetic skin disease that causes redness, scaling, and itching. The cream aims to block certain enzymes that drive the disease. Participants applied the cream to some skin areas and a placebo to …
Phase: PHASE1, PHASE2 • Sponsor: Sixera Pharma • Aim: Disease control
Last updated May 17, 2026 22:01 UTC